Sartorius (SRT3) Given a €162.00 Price Target at Warburg Research

Warburg Research set a €162.00 ($188.37) target price on Sartorius (FRA:SRT3) in a research note published on Wednesday morning, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.

A number of other brokerages also recently issued reports on SRT3. Berenberg Bank set a €110.00 ($127.91) price objective on Sartorius and gave the stock a neutral rating in a research report on Tuesday, January 29th. UBS Group set a €147.00 ($170.93) price objective on Sartorius and gave the stock a neutral rating in a research report on Wednesday, February 20th. Nord/LB set a €115.00 ($133.72) price objective on Sartorius and gave the stock a sell rating in a research report on Tuesday, April 23rd. Deutsche Bank set a €150.00 ($174.42) target price on Sartorius and gave the company a neutral rating in a report on Thursday, April 11th. Finally, HSBC set a €116.00 ($134.88) target price on Sartorius and gave the company a neutral rating in a report on Tuesday, February 5th. Five analysts have rated the stock with a sell rating and four have assigned a hold rating to the company. The stock currently has a consensus rating of Sell and a consensus price target of €129.83 ($150.97).

Shares of FRA:SRT3 opened at €173.20 ($201.40) on Wednesday. Sartorius has a 12-month low of €71.00 ($82.56) and a 12-month high of €124.70 ($145.00).

Sartorius Company Profile

Sartorius Aktiengesellschaft supplies pharmaceutical and laboratory equipment worldwide. It operates in two divisions, Bioprocess Solutions, and Lab Products & Services. The company offers products for suspension cell analysis and live-cell analysis inside incubator for oncology, immuno-oncology, antibody discovery, neuroscience, and stem cell research; cell culture media, including antibody and recombinant protein, viral vaccines, and regenerative medicine media, as well as general media and downstream buffers; and multi-parallel, single-use, benchtop, stainless steel, microbial, and cell culture bioreactors, as well as cell culture expansion systems and software applications for bioreactors.

See Also: The Structure of a Futures Contract

Analyst Recommendations for Sartorius (FRA:SRT3)

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.